{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:27:55Z","timestamp":1787506075851,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jns.2020.117165","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T18:12:40Z","timestamp":1601662360000},"page":"117165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Trends in hospitalizations and epidemiological characteristics of adults Moyamoya disorder in the United States"],"prefix":"10.1016","volume":"419","author":[{"given":"Smit D.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninad","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schweta","family":"Rane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupak","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin D.","family":"Ollenschleger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Starke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyank","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jns.2020.117165_bb0005","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/STROKEAHA.115.012168","article-title":"National analysis of 2454 pediatric Moyamoya admissions and the effect of hospital volume on outcomes","volume":"47","author":"Titsworth","year":"2016","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117165_bb0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fneur.2011.00043","article-title":"Characterization of inpatient moyamoya in the United States: 1988\u20132004","volume":"2","author":"Lee","year":"2011","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2020.117165_bb0015","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1161\/STROKEAHA.113.004273","article-title":"Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study","volume":"45","author":"Ahn","year":"2014","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jns.2020.117165_bb0020","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000345957","article-title":"Epidemiological and clinical features of moyamoya disease in the USA","volume":"40","author":"Kainth","year":"2013","journal-title":"Neuroepidemiology."},{"issue":"1","key":"10.1016\/j.jns.2020.117165_bb0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1227\/NEU.0b013e318253ab8e","article-title":"Moyamoya disorder in the United States","volume":"71","author":"Starke","year":"2012","journal-title":"Neurosurgery."},{"issue":"6","key":"10.1016\/j.jns.2020.117165_bb0030","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/01.wnl.0000176066.33797.82","article-title":"Moyamoya disease in Washington state and California","volume":"65","author":"Uchino","year":"2005","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.jns.2020.117165_bb0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/STROKEAHA.107.490714","article-title":"Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey","volume":"39","author":"Kuriyama","year":"2008","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117165_bb0040","series-title":"Healthcare Cost and Utilization Project (HCUP)","author":"HCUP Home","year":"2020"},{"issue":"2","key":"10.1016\/j.jns.2020.117165_bb0045","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0090-3019(96)00358-8","article-title":"Current state of study on moyamoya disease in Japan","volume":"47","author":"Fukui","year":"1997","journal-title":"Surg. Neurol."},{"issue":"12","key":"10.1016\/j.jns.2020.117165_bb0050","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2176\/nmc.32.883","article-title":"Worldwide distribution of moyamoya disease","volume":"32","author":"Goto","year":"1992","journal-title":"Neurol. Med. Chir."},{"issue":"6","key":"10.1016\/j.jns.2020.117165_bb0055","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1161\/01.STR.0000221787.70503.ca","article-title":"Clinical features and outcome in North American adults with moyamoya phenomenon","volume":"37","author":"Hallemeier","year":"2006","journal-title":"Stroke."},{"issue":"7","key":"10.1016\/j.jns.2020.117165_bb0060","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/01.STR.29.7.1347","article-title":"Clinical features of moyamoya disease in the United States","volume":"29","author":"Chiu","year":"1998","journal-title":"Stroke."},{"issue":"12","key":"10.1016\/j.jns.2020.117165_bb0065","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1161\/STROKEAHA.107.513408","article-title":"Moyamoya disease in Europeans","volume":"39","author":"Kraemer","year":"2008","journal-title":"Stroke."},{"issue":"Suppl. 2","key":"10.1016\/j.jns.2020.117165_bb0070","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S0303-8467(97)00060-7","article-title":"Moyamoya disease in the United States","volume":"99","author":"Numaguchi","year":"1997","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1","key":"10.1016\/j.jns.2020.117165_bb0075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5853\/jos.2015.01627","article-title":"Moyamoya disease: epidemiology, clinical features, and diagnosis","volume":"18","author":"Kim","year":"2016","journal-title":"J. Stroke"},{"key":"10.1016\/j.jns.2020.117165_bb0080","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.wneu.2017.01.012","article-title":"Moyamoya and inflammation","volume":"100","author":"Mejia-Munne","year":"2017","journal-title":"World Neurosurg."},{"issue":"10","key":"10.1016\/j.jns.2020.117165_bb0085","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2176\/nmc.ra.2019-0059","article-title":"Influence of inflammatory disease on the pathophysiology of Moyamoya disease and quasi-moyamoya disease","volume":"59","author":"Mikami","year":"2019","journal-title":"Neurol. Med. Chir."},{"key":"10.1016\/j.jns.2020.117165_bb0090","doi-asserted-by":"crossref","DOI":"10.1161\/str.46.suppl_1.wp421","article-title":"Abstract W P421: trend in concurrent hospitalization for Moyamoya and sickle cell disease: an analysis of Nationwide inpatient sample data","volume":"46","author":"Busani","year":"2015","journal-title":"Stroke."},{"issue":"12","key":"10.1016\/j.jns.2020.117165_bb0095","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1161\/01.STR.28.12.2513","article-title":"A clinical comparison of definite moyamoya disease between South Korea and Japan","volume":"28","author":"Ikezaki","year":"1997","journal-title":"Stroke."},{"issue":"8","key":"10.1016\/j.jns.2020.117165_bb0100","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0025-6196(12)61094-5","article-title":"Moyamoya disease: the disorder and surgical treatment","volume":"69","author":"Ueki","year":"1994","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"10.1016\/j.jns.2020.117165_bb0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5853\/jos.2015.01739","article-title":"Moyamoya disease: treatment and outcomes","volume":"18","author":"Kim","year":"2016","journal-title":"J. Stroke"},{"issue":"12","key":"10.1016\/j.jns.2020.117165_bb0110","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.030","article-title":"Trends of antiplatelet therapy for the management of Moyamoya disease in Japan: results of a nationwide survey","volume":"27","author":"Oki","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"5","key":"10.1016\/j.jns.2020.117165_bb0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2176\/nmc.52.245","volume":"52","author":"Guidelines for Diagnosis and Treatment of Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis)","year":"2012","journal-title":"Neurol. Med. Chir."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20305013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20305013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:51:49Z","timestamp":1758383509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20305013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":23,"alternative-id":["S0022510X20305013"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.117165","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in hospitalizations and epidemiological characteristics of adults Moyamoya disorder in the United States","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.117165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117165"}}